QCI Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

QCI Asset Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-3	Closed	–	–	280
2020 Q1	$0	Hold	3	–	–	﹤0.01%	607
2019 Q4	$0	Hold	3	–	–	﹤0.01%	611
2019 Q3	$0	Sell	3 -23	-88%	-$2.41K	﹤0.01%	614
2019 Q2	$3K	Buy	26 +23	+767%	+$2.45K	﹤0.01%	548
2019 Q1	$0	Hold	3	–	–	﹤0.01%	635
2018 Q4	$0	Hold	3	–	–	﹤0.01%	638
2018 Q3	$0	Sell	3 -48	-94%	-$5.65K	﹤0.01%	599
2018 Q2	$6K	Hold	51	–	–	﹤0.01%	465
2018 Q1	$5K	Hold	51	–	–	﹤0.01%	507
2017 Q4	$5K	Hold	51	–	–	﹤0.01%	515
2017 Q3	$6K	Buy	51 +48	+1,600%	+$5.13K	﹤0.01%	446
2017 Q2	$0	Buy	+3	New	+$295	﹤0.01%	661
2015 Q2	–	Sell	-228	Closed	-$26K	–	517
2015 Q1	$26K	Hold	228	–	–	﹤0.01%	239
2014 Q4	$23K	Buy	228 +138	+153%	+$13.4K	﹤0.01%	269
2014 Q3	$8K	Buy	+90	New	+$7.9K	﹤0.01%	387

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

QCI Asset Management's IBB Position: Q2 2020 in Review

QCI Asset Management sold out of iShares Biotechnology ETF (IBB) in Q2 2020, closing a stake of 3 shares.

QCI Asset Management first reported a position in IBB in Q3 2014 and held it in 15 quarters. The position peaked at $26K in Q1 2015. 766 funds tracked by Wall St. Rank hold IBB as of Q2 2020.

QCI Asset Management reported no remaining iShares Biotechnology ETF position as of Q2 2020 after selling out during the quarter.
QCI Asset Management sold 3 iShares Biotechnology ETF shares in Q2 2020.
QCI Asset Management first reported a position in iShares Biotechnology ETF in Q3 2014 and held it in 15 quarters.
QCI Asset Management's iShares Biotechnology ETF position peaked at $26K in Q1 2015.
766 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2020.

Based on QCI Asset Management's 13F filing for Q2 2020, filed 31 Jul 2020.